...
机译:发现高效,选择性,共价抑制剂的JAK3
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
Bristol-Myers Squibb Research and Development;
JAK3; Covalent; Irreversible inhibitor;
机译:发现高效,选择性,共价抑制剂的JAK3
机译:发现丰富且具有高度选择性的Bruton酪氨酸激酶轴承三嗪脚手架的共价抑制剂
机译:发现MFH290:用于细胞周期蛋白依赖性激酶12/13的有效和高度选择性的共价抑制剂
机译:蛋白表位模拟方法:一种创新的选择性和高效丝氨酸蛋白酶抑制剂的方法
机译:发现和表征针对PEA水解酶,N-酰基乙醇胺水解酸酰胺酶的有效和选择性抑制剂。
机译:发现用于治疗类风湿关节炎的高选择性JAK3抑制剂
机译:伊布鲁替尼的发现:口服,有效和高度选择性,共价镇静的酪氨酸激酶(BTK)抑制剂用于治疗免疫疾病